South Dakota Investment Council’s Acorda Therapeutics ACOR Stock Holding History

South Dakota Investment Council’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Hold	0	–	–	–	635
2021 Q1	–	Sell	-49	Closed	-$6.02K	–	652
2020 Q4	$4K	Hold	49	–	–	﹤0.01%	610
2020 Q3	$3K	Hold	49	–	–	﹤0.01%	599
2020 Q2	$4K	Hold	49	–	–	﹤0.01%	594
2020 Q1	$6K	Hold	49	–	–	﹤0.01%	585
2019 Q4	$12K	Hold	49	–	–	﹤0.01%	584
2019 Q3	$17K	Hold	49	–	–	﹤0.01%	617
2019 Q2	$45K	Hold	49	–	–	﹤0.01%	593
2019 Q1	$78K	Hold	49	–	–	﹤0.01%	586
2018 Q4	$92K	Hold	49	–	–	﹤0.01%	596
2018 Q3	$116K	Buy	+49	New	+$152K	﹤0.01%	603

Other funds holding ACOR

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCA

Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

South Dakota Investment Council's ACOR Position: Q2 2021 in Review

South Dakota Investment Council held its Acorda Therapeutics (ACOR) position steady in Q2 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #635.

South Dakota Investment Council first reported a position in ACOR in Q3 2018 and has held it in 10 quarters since. The position peaked at $116K in Q3 2018. 34 funds tracked by Wall St. Rank hold ACOR as of Q2 2021.

South Dakota Investment Council held 0 shares of Acorda Therapeutics worth $0 as of Q2 2021.
South Dakota Investment Council left its Acorda Therapeutics share count unchanged in Q2 2021.
Acorda Therapeutics made up ﹤0.01% of South Dakota Investment Council's portfolio in Q2 2021, its #635 holding.
South Dakota Investment Council first reported a position in Acorda Therapeutics in Q3 2018 and has held it in 10 quarters since.
South Dakota Investment Council's Acorda Therapeutics position peaked at $116K in Q3 2018.
34 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2021.

Based on South Dakota Investment Council's 13F filing for Q2 2021, filed 11 Aug 2021.